Tapewire

Nasdaq · USD

ALEC

Alector, Inc.

Export transactions ↓
Tapewire entity
6051
SEC CIK
0001653087
Parsed reports
298

Last 12 months

Inside the activity.

0 purchase rows · 21 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202505
Jan 202600
Feb 202601
Mar 202605
Apr 202601
May 202600
Jun 202604
Jul 202600
Aug 202600
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 02, 2025 Filed Sep 4, 2025 20:27 UTC
Rosenthal ArnonDirector · Chief Executive Officer
SaleCommon Stock 51,562 $2.50 $128,740.00
Disclosure

SEC source: 0001415889-25-023670 · form4-09042025_080945.xml · nonDerivative · entry 1

Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,350,220

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.30 to $2.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

F3 · balance_after: The reported amount excludes 150,000 shares previously reported as performance share units, or PSUs. Because the performance metrics were not attained during the PSU measurement period, these PSUs were forfeited on May 6, 2025.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 20:33 UTC
Wong-Sarad GracePrincipal Accounting Officer
SaleCommon Stock 5,910 $2.50 $14,756.09
Disclosure

SEC source: 0001415889-25-023686 · form4-09042025_080941.xml · nonDerivative · entry 1

Wong-Sarad Grace · CIK 0002074667 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,448

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.30 to $2.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 20:32 UTC
Berkley Neil LindsayPrincipal Financial Officer
SaleCommon Stock 15,842 $2.50 $39,554.31
Disclosure

SEC source: 0001415889-25-023683 · form4-09042025_080917.xml · nonDerivative · entry 1

Berkley Neil Lindsay · CIK 0002075298 · Principal Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 346,570

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.30 to $2.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
August 26, 2025 Filed Aug 27, 2025 22:37 UTC SaleCommon Stock 14,000 $2.36 $32,998.00
Disclosure

SEC source: 0001415889-25-023187 · form4-08272025_100849.xml · nonDerivative · entry 1

Hammond Paula · CIK 0001805348 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,909

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 27, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.31 to $2.385. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
July 01, 2025 Filed Jul 1, 2025 21:00 UTC
Kenkare-Mitra SaraPresident and Head of R&D
GrantEmployee Stock Option (right to buy) · Derivative 18,250 $0.00 Strike: $1.42 $0.00
Disclosure

SEC source: 0000950170-25-092313 · ownership.xml · derivative · entry 2

Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,250

Underlying: Common Stock · 18,250 shares

Expires 2035-07-01

F2 · derivative.exercise_date: One third (1/3rd) of the total shares subject to the option shall vest on November 1, 2025, and one twelfth (1/12th) of the total shares subject to the option shall vest in equal monthly installments thereafter, provided that the shares subject to the option will vest in full on July 1, 2026.

Read SEC document
July 01, 2025 Filed Jul 1, 2025 21:00 UTC
Kenkare-Mitra SaraPresident and Head of R&D
GrantCommon Stock 54,725 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-092313 · ownership.xml · nonDerivative · entry 1

Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 566,977

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, one half (1/2) of the total shares shall vest on December 1, 2025 and one fourth (1/4th) of the total shares shall vest quarterly thereafter.

Read SEC document
July 01, 2025 Filed Jul 1, 2025 21:00 UTC
Rosenthal ArnonDirector · Chief Executive Officer
GrantEmployee Stock Option (right to buy) · Derivative 45,700 $0.00 Strike: $1.42 $0.00
Disclosure

SEC source: 0000950170-25-092312 · ownership.xml · derivative · entry 6

Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,700

Underlying: Common Stock · 45,700 shares

Expires 2035-07-01

F6 · derivative.exercise_date: One third (1/3rd) of the total shares subject to the option shall vest on November 1, 2025, and one twelfth (1/12th) of the total shares subject to the option shall vest in equal monthly installments thereafter, provided that the shares subject to the option will vest in full on July 1, 2026.

Read SEC document
July 01, 2025 Filed Jul 1, 2025 21:00 UTC
Rosenthal ArnonDirector · Chief Executive Officer
GrantCommon Stock 137,125 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-092312 · ownership.xml · nonDerivative · entry 1

Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,551,782

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, one half (1/2) of the total shares shall vest on December 1, 2025 and one fourth (1/4th) of the total shares shall vest quarterly thereafter.

Read SEC document
July 01, 2025 Filed Jul 1, 2025 21:00 UTC
Berkley Neil LindsayPrincipal Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 18,000 $0.00 Strike: $1.42 $0.00
Disclosure

SEC source: 0000950170-25-092314 · ownership.xml · derivative · entry 1

Berkley Neil Lindsay · CIK 0002075298 · Principal Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2035-07-01

F1 · derivative.exercise_date: One third (1/3rd) of the total shares subject to the option shall vest on November 1, 2025, and one twelfth (1/12th) of the total shares subject to the option shall vest in equal monthly installments thereafter, provided that the shares subject to the option will vest in full on July 1, 2026.

Read SEC document
June 20, 2025 Filed Jun 23, 2025 20:05 UTC SaleCommon Stock 1,000 $1.44 $1,440.00
Disclosure

SEC source: 0000950170-25-088968 · ownership.xml · nonDerivative · entry 1

Yaffe Kristine · CIK 0001783895 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,409

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantStock Option (right to buy) · Derivative 9,450 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0000950170-25-085620 · ownership.xml · derivative · entry 2

Hammond Paula · CIK 0001805348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,450

Underlying: Common Stock · 9,450 shares

Expires 2035-06-10

F2 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantCommon Stock 28,700 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-085620 · ownership.xml · nonDerivative · entry 1

Hammond Paula · CIK 0001805348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,909

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantStock Option (right to buy) · Derivative 9,450 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0000950170-25-085614 · ownership.xml · derivative · entry 2

Altmeyer Mark · CIK 0001643074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,450

Underlying: Common Stock · 9,450 shares

Expires 2035-06-10

F2 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantCommon Stock 28,700 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-085614 · ownership.xml · nonDerivative · entry 1

Altmeyer Mark · CIK 0001643074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,950

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantStock Option (right to buy) · Derivative 9,450 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0000950170-25-085615 · ownership.xml · derivative · entry 2

DESOUZA ERROL B · CIK 0001213895 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,450

Underlying: Common Stock · 9,450 shares

Expires 2035-06-10

F2 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantCommon Stock 28,700 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-085615 · ownership.xml · nonDerivative · entry 1

DESOUZA ERROL B · CIK 0001213895 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,950

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantStock Option (right to buy) · Derivative 9,450 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0000950170-25-085616 · ownership.xml · derivative · entry 3

LAVIGNE LOUIS J JR · CIK 0001214127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,450

Underlying: Common Stock · 9,450 shares

Expires 2035-06-10

F3 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantCommon Stock 28,700 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-085616 · ownership.xml · nonDerivative · entry 1

LAVIGNE LOUIS J JR · CIK 0001214127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,409

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantStock Option (right to buy) · Derivative 9,450 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0000950170-25-085617 · ownership.xml · derivative · entry 2

SCHELLER RICHARD H · CIK 0001214133 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,450

Underlying: Common Stock · 9,450 shares

Expires 2035-06-10

F2 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantCommon Stock 28,700 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-085617 · ownership.xml · nonDerivative · entry 1

SCHELLER RICHARD H · CIK 0001214133 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,366

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantStock Option (right to buy) · Derivative 9,450 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0000950170-25-085618 · ownership.xml · derivative · entry 2

GAROFALO ELIZABETH A. · CIK 0001826361 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,450

Underlying: Common Stock · 9,450 shares

Expires 2035-06-10

F2 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantCommon Stock 28,700 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-085618 · ownership.xml · nonDerivative · entry 1

GAROFALO ELIZABETH A. · CIK 0001826361 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,950

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantStock Option (right to buy) · Derivative 9,450 $0.00 Strike: $1.63 $0.00
Disclosure

SEC source: 0000950170-25-085619 · ownership.xml · derivative · entry 2

Yaffe Kristine · CIK 0001783895 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,450

Underlying: Common Stock · 9,450 shares

Expires 2035-06-10

F2 · derivative.exercise_date: The shares subject to the option vest in 12 equal monthly installments beginning on July 11, 2025, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 22:05 UTC GrantCommon Stock 28,700 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-085619 · ownership.xml · nonDerivative · entry 1

Yaffe Kristine · CIK 0001783895 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,409

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:19 UTC
Kenkare-Mitra SaraPresident and Head of R&D
SaleCommon Stock 23,890 $1.34 $31,974.38
Disclosure

SEC source: 0001415889-25-015585 · form4-06042025_080634.xml · nonDerivative · entry 1

Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 512,252

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.285 to $1.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:18 UTC
Rosenthal ArnonDirector · Chief Executive Officer
SaleCommon Stock 52,087 $1.34 $69,713.24
Disclosure

SEC source: 0001415889-25-015583 · form4-06042025_080624.xml · nonDerivative · entry 1

Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,414,657

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.285 to $1.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:21 UTC
GRASSO MARCChief Financial Officer
SaleCommon Stock 16,488 $1.34 $22,067.54
Disclosure

SEC source: 0001415889-25-015591 · form4-06042025_080614.xml · nonDerivative · entry 1

GRASSO MARC · CIK 0001748894 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,072

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.285 to $1.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
May 02, 2025 Filed May 2, 2025 22:00 UTC GrantCommon Stock 15,833 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-062995 · ownership.xml · nonDerivative · entry 1

SCHELLER RICHARD H · CIK 0001214133 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,666

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in 4 equal quarterly installments beginning on June 1, 2025.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:05 UTC
Kenkare-Mitra SaraPresident and Head of R&D
SaleCommon Stock 29,073 $1.47 $42,661.72
Disclosure

SEC source: 0000950170-25-033534 · ownership.xml · nonDerivative · entry 1

Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 536,142

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.4673 to $1.4676. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 16:05 UTC
Romano GaryChief Medical Officer
SaleCommon Stock 16,306 $1.47 $23,927.42
Disclosure

SEC source: 0000950170-25-033520 · ownership.xml · nonDerivative · entry 1

Romano Gary · CIK 0001799779 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 332,977

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.4673 to $1.4686. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:05 UTC
Rosenthal ArnonDirector · Chief Executive Officer
SaleCommon Stock 40,330 $1.47 $59,176.21
Disclosure

SEC source: 0000950170-25-033530 · ownership.xml · nonDerivative · entry 1

Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,466,744

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.4673 to $1.4674. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:05 UTC
GRASSO MARCChief Financial Officer
SaleCommon Stock 18,091 $1.47 $26,546.73
Disclosure

SEC source: 0000950170-25-033539 · ownership.xml · nonDerivative · entry 1

GRASSO MARC · CIK 0001748894 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 312,560

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.4673 to $1.4678. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
December 02, 2024 Filed Dec 3, 2024 22:40 UTC
Kenkare-Mitra SaraPresident and Head of R&D
SaleCommon Stock 26,500 $2.52 $66,764.10
Disclosure

SEC source: 0000950170-24-132911 · ownership.xml · nonDerivative · entry 1

Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 565,215

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.5193 to $2.5194. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
December 02, 2024 Filed Dec 3, 2024 17:40 UTC
Romano GaryChief Medical Officer
SaleCommon Stock 14,892 $2.52 $37,518.90
Disclosure

SEC source: 0000950170-24-132910 · ownership.xml · nonDerivative · entry 1

Romano Gary · CIK 0001799779 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349,283

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.5194 to $2.5197. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
December 02, 2024 Filed Dec 3, 2024 22:40 UTC
Rosenthal ArnonDirector · Chief Executive Officer
SaleCommon Stock 52,172 $2.52 $131,442.14
Disclosure

SEC source: 0000950170-24-132912 · ownership.xml · nonDerivative · entry 1

Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,507,074

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.5193 to $2.5194. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
December 02, 2024 Filed Dec 3, 2024 22:40 UTC
GRASSO MARCChief Financial Officer
SaleCommon Stock 16,489 $2.52 $41,542.39
Disclosure

SEC source: 0000950170-24-132913 · ownership.xml · nonDerivative · entry 1

GRASSO MARC · CIK 0001748894 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 330,651

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.5193 to $2.5195. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:05 UTC
Kenkare-Mitra SaraPresident and Head of R&D
GrantCommon Stock 300,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-111422 · ownership.xml · nonDerivative · entry 1

Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 591,715

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on December 1, 2024.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 16:05 UTC
Romano GaryChief Medical Officer
GrantCommon Stock 184,380 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-111419 · ownership.xml · nonDerivative · entry 1

Romano Gary · CIK 0001799779 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 364,175

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on December 1, 2024.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:05 UTC
Rosenthal ArnonDirector · Chief Executive Officer
GrantCommon Stock 610,500 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-111421 · ownership.xml · nonDerivative · entry 1

Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,559,246

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on December 1, 2024.

Read SEC document
October 01, 2024 Filed Oct 2, 2024 20:05 UTC
GRASSO MARCChief Financial Officer
GrantCommon Stock 216,400 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-111426 · ownership.xml · nonDerivative · entry 1

GRASSO MARC · CIK 0001748894 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 347,140

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on December 1, 2024.

Read SEC document
September 03, 2024 Filed Sep 4, 2024 20:15 UTC
Kenkare-Mitra SaraPresident and Head of R&D
SaleCommon Stock 13,926 $4.88 $67,981.16
Disclosure

SEC source: 0000950170-24-103407 · ownership.xml · nonDerivative · entry 1

Kenkare-Mitra Sara · CIK 0001895592 · President and Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 291,715

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.8815 to $4.8818. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
September 03, 2024 Filed Sep 4, 2024 16:15 UTC
Romano GaryChief Medical Officer
SaleCommon Stock 8,478 $4.88 $41,385.36
Disclosure

SEC source: 0000950170-24-103406 · ownership.xml · nonDerivative · entry 1

Romano Gary · CIK 0001799779 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,795

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.8814 to $4.8820. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
September 03, 2024 Filed Sep 4, 2024 20:15 UTC
Rosenthal ArnonDirector · Chief Executive Officer
SaleCommon Stock 26,499 $4.88 $129,386.67
Disclosure

SEC source: 0000950170-24-103408 · ownership.xml · nonDerivative · entry 1

Rosenthal Arnon · CIK 0001757770 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,948,746

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.8827 to $4.8828. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
September 03, 2024 Filed Sep 4, 2024 20:44 UTC
GRASSO MARCChief Financial Officer
SaleCommon Stock 7,297 $4.88 $35,620.31
Disclosure

SEC source: 0000950170-24-103454 · ownership.xml · nonDerivative · entry 1

GRASSO MARC · CIK 0001748894 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,740

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.8815 to $4.8816. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
August 22, 2024 Filed Aug 23, 2024 20:05 UTC SaleCommon Stock 44,250 $5.16 $228,387.53
Disclosure

SEC source: 0000950170-24-100168 · ownership.xml · nonDerivative · entry 1

SCHELLER RICHARD H · CIK 0001214133 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.045 to $5.230. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
August 12, 2024 Filed Aug 13, 2024 23:55 UTC SaleCommon Stock 10,500 $5.06 $53,179.35
Disclosure

SEC source: 0000950170-24-096566 · ownership.xml · nonDerivative · entry 1

Hammond Paula · CIK 0001805348 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,209

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 10, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.005 to $5.160. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
August 12, 2024 Filed Aug 13, 2024 23:55 UTC SaleCommon Stock 5,000 $5.06 $25,309.00
Disclosure

SEC source: 0000950170-24-096565 · ownership.xml · nonDerivative · entry 1

Yaffe Kristine · CIK 0001783895 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,709

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 10, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.01 to $5.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request.

Read SEC document
August 02, 2024 Filed Oct 10, 2024 20:05 UTC GrantCommon Stock 15,833 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-114050 · ownership.xml · nonDerivative · entry 1

SCHELLER RICHARD H · CIK 0001214133 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,833

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest in 4 equal quarterly installments beginning on September 1, 2024.

F2 · balance_after: The reported amounts in Column 5 of Table I reflect the Reporting Person's beneficial ownership as of the date of filing this Form 4.

Read SEC document
June 12, 2024 Filed Jun 12, 2024 20:46 UTC GrantCommon Stock 35,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-072513 · ownership.xml · nonDerivative · entry 1

Hammond Paula · CIK 0001805348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,709

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 12, 2025 or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 12, 2024 Filed Jun 12, 2024 20:46 UTC GrantCommon Stock 35,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-072518 · ownership.xml · nonDerivative · entry 1

LAVIGNE LOUIS J JR · CIK 0001214127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,709

F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 12, 2025 or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.